![Steven Lommel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Steven Lommel
Oprichter bij
NanoVector, Inc.
Profiel
Steven Lommel is the founder of NanoVector, Inc., which was founded in 2002.
He holds the title of Scientific Advisor at NanoVector, Inc. Dr. Lommel is currently the Director at The North Carolina Biotechnology Center and the President at The David H.
Murdock Research Institute.
Actieve functies van Steven Lommel
| Bedrijven | Functie | Begin |
|---|---|---|
NanoVector, Inc.
 NanoVector, Inc. Medical SpecialtiesHealth Technology Develops nanoparticle drug delivery system | Oprichter | 18-09-2009 |
The David H. Murdock Research Institute
 The David H. Murdock Research Institute Miscellaneous Commercial ServicesCommercial Services Provides integrated, state-of-the-art genomic, cellular, proteomic and bioinformatics technology platforms | President | 03-07-2012 |
The North Carolina Biotechnology Center
 The North Carolina Biotechnology Center Internet Software/ServicesTechnology Services Provides research and education grants | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
50
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
The North Carolina Biotechnology Center
The North Carolina Biotechnology Center Internet Software/ServicesTechnology Services Provides research and education grants | Technology Services |
NanoVector, Inc.
NanoVector, Inc. Medical SpecialtiesHealth Technology Develops nanoparticle drug delivery system | Health Technology |
The David H. Murdock Research Institute
The David H. Murdock Research Institute Miscellaneous Commercial ServicesCommercial Services Provides integrated, state-of-the-art genomic, cellular, proteomic and bioinformatics technology platforms | Commercial Services |
